Switching from methadone to diamorphine-2-year results of the german heroin-assisted treatment trial

Substance Use and Misuse

Volumn 46, Issue 8, 2011, Pages 980-991

  Verthein, Uwe ^a   Haasen, Christian ^a   Reimer, Jens ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

diacetylmorphine; difficult to treat; heroin assisted treatment; longitudinal study; methadone maintenance treatment; opiate dependence

Indexed keywords

DIAMORPHINE; METHADONE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SUBSTITUTION; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALGESICS, OPIOID; DRUG SUBSTITUTION; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; TREATMENT OUTCOME;

EID: 79957518778     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.540624     Document Type: Article

References (31)

1. Blanken, P., Hendriks, V. M., Van Den Brink, W., & van Ree, J. M. (2005). Heroin auf rezept für die behandlung von therapieresistenten chronisch heroinabhängigen. Die resultate niederländischer studien und der aktuelle stand [Medical prescription of heroin to treatment resistant chronic heroin addicts. Results of the Dutch studies and state of affairs]. Konturen, 26(6), 18-21.
2. Central Committee on the Treatment of Heroin Addicts. (2002). Medical co-prescription heroin. Two randomized controlled trials. Utrecht: Author.
3. Darke, S., Ward, J., Zador, D., & Swift, G. (1991). A scale for estimating the health status of opioid users. British Journal of Addiction, 86, 1317-1322.
4. Degkwitz, P., Lichtermann, D., Deibler, P., Soyka, M., Schneider, U., Dieninghoff, D., et al. (2007). "Schwerstabhängige"-Die teilnehmer des modellprojekts zur heroingestützten behandlung ["Heavy injection drug users"-The participants of the trial on heroin-based treatment]. Suchttherapie, 8, 12-18.
5. Derogatis, L. R. (1983). SCL-90-R: Administration, scoring and procedures. Manual II. Towsen, MD: Clinical Psychometric Research.
6. Farnbacher, G., Brückner, E., & Haasen, C. (2008). Manual zur psychoedukation opiatabhängiger menschen [Manual of psycho-educative group therapy for opiate dependent persons]. Freiburg, Germany: Lambertus.
7. Fischer, B., Oviedo-Joeckes, E., Blanken, P., Haasen, C., Rehm, J. Schechter, M. T., et al. (2007). Heroin-assisted treatment (HAT) a decade later: A brief update on science and politics. Journal of Urban Health, 84, 552-562. (Pubitemid 47075056)
8. Gsellhofer, B., Küfner, H., Vogt, M., & Weiler, D. (1999). European addiction severity index EuropASI. Nach der 5. Auflage der amerikanischen version von McLellan und der Europäischen version des ASI. Baltmannsweiler, Germany: Schneider Verlag Hohengehren.
9. Güttinger, F., Gschwend, P., Schulte, B., Rehm, J., & Uchtenhagen, A. (2002).Die lebenssituation von drogenabhängigen der heroin gestützten behandlung in der Schweiz-Eine 6-jahreskatamnese [The social situation of patients and ex-patients of heroin-assisted treatment in Switzerland-A six year follow-up study]. Sucht, 48, 370-378. (Pubitemid 35364372)
10. Güttinger, F., Gschwend, P., Schulte, B., Rehm, J., & Uchtenhagen, A. (2003). Evaluating long-term effects of heroinassisted treatment-The results of a 6-year follow-up. European Addiction Research, 9, 73-79. (Pubitemid 36351187)
11. Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence. Randomised controlled trial. British Journal of Psychiatry, 191, 55-62. (Pubitemid 47035182)
12. Hartnoll, R. L., Mitcheson, M. C., Battersby, A., Brown, G., Ellis, M., Fleming, P., et al. (1980). Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry, 37, 877-884. (Pubitemid 10034563)
13. Koeter, M.W. J., & Hartgers, C. (1997). European addiction severity index EuropASI. Cost A6. Preliminary procedure for the computation of the EuropASI composite scores. Amsterdam: The Amsterdam Institute for Addiction Research.
14. Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1, 208-210.
15. Kuhn, S., Farnbacher, G., Verthein, U., Krausz, M., & Haasen, C. (2007). Das psychoedukative Gruppenprogramm in der bundesdeutschen Heroinstudie-Eine innovative Behandlungsmethode [Psychoeducation within the German heroin trial-An innovative treatment approach]. Suchttherapie, 8, 26-32.
16. Lintzeris, N., Strang, J., Metrebian, N., Byford, S., Hallam, C., Lee, S., et al. (2006). Methodology for the randomised injecting opioid treatment trial (RIOTT): Evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduction Journal, 3, 28-40.
17. Löbmann, R., & Verthein, U. (2009). Explaining the effectiveness of medical treatment for heroin addicts on crime reductions. Law and Human Behavior, 33, 83-95.
18. March, J. C., Oviedo-Joekes, E., Perea-Milla, E., Carrasco, F., & the PEPSA Team. (2006). Controlled trial of prescribed heroin in the treatment of opioid addiction. Journal of Substance Abuse Treatment, 31, 203-211. (Pubitemid 44223911)
19. Metrebian, N., Shanahan, W., Wells, B., & Stimson, G. V. (1998). Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: Associated health gains and harm reductions. The Medical Journal of Australia, 168, 596-600. (Pubitemid 28288616)
20. NAOMI Study Team. (2008). Reaching the hardest to reach-Treating the hardest-to-treat. Summary of the primary outcomes of the North American Opiate Medication Initiative (NAOMI). Vancouver, BC: Author.
21. Oviedo-Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D., Anis, A., et al. (2009). Diacetylmorphine versus methadone for the treatment of opioid addiction. New England Journal of Medicine, 361, 777-786.
22. Oviedo-Joekes, E., Nosyk, B., Brissette, S., Chettiar, J., Schneeberger, P., Marsh, D. C., et al. (2008). The North American Opiate Medication Initiative (NAOMI): Profile of participants in North America's first trial of heroin-assisted treatment. Journal of Urban Health, 85, 812-825.
23. Perneger, T. V., Giner, F., del Rio, M., & Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13-18. (Pubitemid 28333818)
24. Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A., & Uchtenhagen, A. (2001). Feasibility, saftey, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet, 358, 1417-1423.
25. Ribeaud, D. (2005). Gibt es einen Delinquenzrückgang durch soziale Reintegration im Rahmen der schweizerischen Heroinverschreibungsversuche? [Is there a reduction in crime through social reintegration in the context of the Swiss heroin trials?]. Sucht, 51, 76-87. (Pubitemid 40754626)
26. Uchtenhagen, A., Dobler-Mikola, A., Steffen, T., Gutzwiller, F., Blättler, R., & Pfeifer, S. (1999). Prescription of narcotics for heroin addicts. Basel, Switzerland: Karger.
27. van den Brink, W., Hendriks, V. M., Blanken, P., Koeter, M. W. J., van Zwieten, B. J., & van Ree, J. M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal, 327, 310-315.
28. van den Brink, W., Hendriks, V. M., & van Ree, J. M. (1999). Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands. Journal of Drug Issues, 29, 587-607.
29. Verthein, U., Bonorden-Kleij, K., Degkwitz, P., Dilg, C., Köhler,W. K., Passie, T., et al. (2008). Long-term effects of heroin-assisted treatment in Germany. Addiction, 103, 960-966. (Pubitemid 351703473)
30. Ville de Lìege-Coordination des Actions en Toxicomanie. (2007). H́eröine ̀a usage ḿedical. Projet pilote de traitement assist́e pardiac ́etylmorphine. Lìege: Author.
31. Vogt, I., Schmid, M., Schu, M., Simmedinger, R., & Schlanstedt, G. (2007). Motivierendes Case Management (MOCA) in der deutschen Studie zur heroin-gestützten behandlung von opiatabhängigen [Motivational case management in the German study on heroin-supported treatment of opiate dependents]. Suchttherapie, 8, 19-25.